Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis

Area of Science:

• Oncology
• Cancer Biology
• Molecular Oncology

Background:

• Small-cell lung cancer (SCLC) is known for its aggressive metastatic behavior.
• The precise cellular origins of SCLC metastasis have remained unclear.
• Understanding SCLC cell plasticity is crucial for developing effective treatments.

Purpose of the Study:

• To identify the specific cell type responsible for SCLC metastasis.
• To elucidate the molecular mechanisms driving SCLC cell transition and metastasis.
• To investigate the role of TAZ in regulating SCLC plasticity and metastatic potential.

Main Methods:

• Utilized a Rb1/Trp53 conditional knockout mouse model of SCLC.
• Employed single-cell RNA-sequencing and chromatin accessibility profiling.
• Investigated the function of the SWI/SNF complex and TAZ through gene knockout and knockdown/overexpression studies.

Main Results:

• Identified NCAMhiCD44lo/- cells as the SCLC metastasizing cells (SMCs), originating from NCAMloCD44hi non-SMCs.
• Demonstrated that SWI/SNF complex activity, particularly Brg1, drives this phenotypic transition and metastasis.
• Showed that SWI/SNF-mediated TAZ silencing promotes SMC transition, while TAZ re-expression reverses it and reduces metastasis.
• Confirmed SMCs as the dominant subpopulation in human SCLC metastasis and found TAZ expression correlates with better patient prognosis.

Conclusions:

• SCLC exhibits significant cellular plasticity, enabling metastatic progression.
• The SWI/SNF complex and TAZ act as critical regulators of SCLC cell state transitions.
• TAZ functions as a key molecular switch controlling SCLC metastasis, offering a potential therapeutic target.